Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01165112
Brief Title: Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma (TREC)

First Submitted : June 21, 2010
First Submitted that Met QC Criteria : July 16, 2010
First Posted : July 19, 2010 (Estimate)

Results First Submitted : April 17, 2017
Results First Submitted that Met QC Criteria : April 17, 2017
Results First Posted : May 25, 2017

Last Update Submitted that Met QC Criteria : November 9, 2018
Last Update Posted : December 5, 2018